Abstract
There are few models in which HIV pathogenesis, particularly gut-associated lymphoid tissue CD4+ T-cell depletion, can be studied and in which potential clinical interventions against HIV disease can be evaluated. HIV cannot be studied in normal mice due to the limited species tropism of the virus. Through the pioneering efforts of many investigators, humanized mice are now routinely used to rapidly advance HIV research. It is important to recognize that not all humanized murine models are equal, and their strengths and weaknesses must be taken into consideration to obtain information that is most relevant to the human condition. This review distinguishes the major humanization protocols and highlights each model’s recent contributions to HIV research, including mucosal transmission, gut-associated lymphoid tissue pathogenesis, and the evaluation of novel therapeutic and prevention approaches to potentially treat HIV disease and prevent the further spread of AIDS.
Similar content being viewed by others
References and Recommended Reading
Mosier DE, Gulizia RJ, Baird SM, Wilson DB: Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988, 335:256–259.
Baumann JG, Unutmaz D, Miller MD, et al.: Murine T cells potently restrict human immunodeficiency virus infection. J Virol 2004, 78:12537–12547.
McCune J, Kaneshima H, Krowka J, et al.: The SCID-hu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol 1991, 9:399–429.
McCune JM, Kaneshima H, Lieberman M, et al.: The SCID-hu mouse: current status and potential applications. Curr Top Microbiol Immunol 1989, 152:183–193.
Brenchley JM, Price DA, Douek DC: HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006, 7:235–239.
Dandekar S: Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep 2007, 4:10–15.
Shultz LD, Ishikawa F, Greiner DL: Humanized mice in translational biomedical research. Nat Rev Immunol 2007, 7:118–130.
Garcia S, Dadaglio G, Gougeon ML: Limits of the human-PBL-SCID mice model: severe restriction of the V beta T-cell repertoire of engrafted human T cells. Blood 1997, 89:329–336.
Saxon A, Macy E, Denis K, et al.: Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J Clin Invest 1991, 87:658–665.
McCune JM, Namikawa R, Kaneshima H, et al.: The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988, 241:1632–1639.
D’Cruz OJ, Uckun FM: Limitations of the human-PBLSCID mouse model for vaginal transmission of HIV-1. Am J Reprod Immunol 2007, 57:353–360.
Di Fabio S, Van Roey J, Giannini G, et al.: Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation. AIDS 2003, 17:1597–1604.
Khanna KV, Whaley KJ, Zeitlin L, et al.: Vaginal transmission of cell-associated HIV-1 in the mouse is blocked by a topical, membrane-modifying agent. J Clin Invest 2002, 109:205–211.
Lederman MM, Offord RE, Hartley O: Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol 2006, 6:371–382.
Su L, Kaneshima H, Bonyhadi M, et al.: HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo. Immunity 1995, 2:25–36.
Stoddart CA, Bales CA, Bare JC, et al.: Validation of the SCID-hu thy/liv mouse model with four classes of licensed antiretrovirals. PLoS ONE 2007, 2:e655.
Traggiai E, Chicha L, Mazzucchelli L, et al.: Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004, 304:104–107.
Manz MG: Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 2007, 26:537–541.
Berges BK, Wheat WH, Palmer BE, et al.: HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model. Retrovirology 2006, 3:76.
Ter Brake O, Legrand N, von Eije KJ, et al.: Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)(c)(-/-)) mouse model. Gene Ther 2008 Jul 31 (Epub ahead of print).
Van Duyne R, Cardenas J, Easley R, et al.: Effect of transcription peptide inhibitors on HIV-1 replication. Virology 2008, 376:308–322.
An DS, Poon B, Ho Tsong, et al.: Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection. Clin Vaccine Immunol 2007, 14:391–396.
Baenziger S, Tussiwand R, Schlaepfer E, et al.: Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci U S A 2006, 103:15951–15956.
Berges BK, Akkina SR, Folkvord JM, et al.: Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gamma c -/- (RAG-hu) mice. Virology 2008, 373:342–351.
Gorantla S, Sneller H, Walters L, et al.: Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol 2007, 81:2700–2712.
Jiang Q, Zhang L, Wang R, et al.: FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo. Blood 2008, 112:2858–2868.
Zhang L, Kovalev GI, Su L: HIV-1 infection and pathogenesis in a novel humanized mouse model. Blood 2007, 109:2978–2981.
Hiramatsu H, Nishikomori R, Heike T, et al.: Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammcnull mice model. Blood 2003, 102:873–880.
Ishikawa F, Yasukawa M, Lyons B, et al.: Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood 2005, 106:1565–1573.
Watanabe S, Ohta S, Yajima M, et al.: Humanized NOD/SCID/IL2R {gamma}null mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007, 81:13259–13264.
Watanabe S, Terashima K, Ohta S, et al.: Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007, 109:212–218.
Kumar P, Ban HS, Kim SS, et al.: T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 2008, 134:577–586.
Melkus MW, Estes JD, Padgett-Thomas A, et al.: Humanized mice mount specific adaptive and innate immune response to EBV and TSST-1. Nat Med 2006, 12:1316–1322.
Wege AK, Melkus MW, Denton PW, et al.: Functional and phenotypic characterization of the humanized BLT mouse model. Curr Top Microbiol Immunol 2008, 324:149–165.
Tonomura N, Habiro K, Shimizu A, et al.: Antigen-specific human T-cell responses and T cell-dependent production of human antibodies in a humanized mouse model. Blood 2008, 111:4293–4296.
Lan P, Tonomura N, Shimizu A, et al.: Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation. Blood 2006, 108:487–492.
Tonomura N, Shimizu A, Wang S, et al.: Pig islet xenograft rejection in a mouse model with an established human immune system. Xenotransplantation 2008, 15:129–135.
Makida R, Hofer MF, Takase K, et al.: Bacterial superantigens induce V beta-specific T cell receptor internalization. Mol Immunol 1996, 33:891–900.
Sun Z, Denton PW, Estes JD, et al.: Intrarectal transmission, systemic infection and CD4+ T cell depletion in humanized mice infected with HIV-1. J Exp Med 2007, 204:705–714.
Hofer U, Baenziger S, Heikenwalder M, et al.: RAG2-/- gamma(c)-/- mice transplanted with CD34+ cells from human cord blood show low levels of intestinal engraftment and are resistant to rectal transmission of human immunodeficiency virus. J Virol 2008, 82:12145–12153.
Brenchley JM, Schacker TW, Ruff LE, et al.: CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004, 200:749–759.
Bell SJ, Rigby R, English N, et al.: Migration and maturation of human colonic dendritic cells. J Immunol 2001, 166:4958–4967.
Abuzakouk M, Carton J, Feighery C, et al.: CD4+ CD8+ and CD8alpha+ beta-T lymphocytes in human small intestinal lamina propria. Eur J Gastroenterol Hepatol 1998, 10:325–329.
Carton J, Byrne B, Madrigal-Estebas L, et al.: CD4+CD8+ human small intestinal T cells are decreased in coeliac patients, with CD8 expression downregulated on intraepithelial T cells in the active disease. Eur J Gastroenterol Hepatol 2004, 16:961–968.
Lynch S, Kelleher D, Feighery C, et al.: Flow cytometric analysis of intraepithelial lymphocytes from human small intestinal biopsies reveals populations of CD4+CD8+ and CD8[alpha][alpha]+ cells. Eur J Gastroenterol Hepatol 1993, 5:907–912.
Denton PW, Estes JD, Sun Z, et al.: Antiretroviral preexposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008, 5:e16.
Foster JL, Garcia JV: Role of Nef in HIV-1 replication and pathogenesis. Adv Pharmacol 2007, 55:389–409.
De Boer RJ: Understanding the failure of CD8+ T-cell vaccination against simian/human immunodeficiency virus. J Virol 2007, 81:2838–2848.
Koff WC, Johnson PR, Watkins DI, et al.: HIV vaccine design: insights from live attenuated SIV vaccines. Nat Immunol 2006, 7:19–23.
McMichael AJ, Hanke T: HIV vaccines 1983–2003. Nat Med 2003, 9:874–880.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Denton, P.W., Garcia, J.V. Novel humanized murine models for HIV research. Curr HIV/AIDS Rep 6, 13–19 (2009). https://doi.org/10.1007/s11904-009-0003-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11904-009-0003-2